Clinical Trial Update: PET Study of Breast Cancer Patients Using [68Ga]ABY-025 [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase 1/2 clinical trial evaluating the PET imaging tracer [68Ga]ABY-025 in breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• [68Ga]ABY-025 (ABY-025)

Snippet

Sponsor: Biomedical Radiation Sciences | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED